Skip to main content

Advertisement

SpringerLink
Log in

The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Boeckh M, Gallez-Hawkins G, Myerson D, Zaia J, Bowden R . Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 1997; 64: 108–113.

    Article  CAS  Google Scholar 

  2. Solano C, Munoz I, Gutierrez A, Farga A, Prosper F, Garcia-Conde J et al. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation. J Clin Microbiol 2001; 39: 3938–3941.

    Article  CAS  Google Scholar 

  3. Lengerke C, Ljubicic T, Meisner C, Loeffler J, Sinzger C, Einsele H et al. Evaluation of the COBAS Amplicor HCMV monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 38: 53–60.

    Article  CAS  Google Scholar 

  4. Centers for Disease Control Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 2000; 49 (No. RR-10): 1–125.

    Google Scholar 

  5. Mori T, Okamoto S, Watanabe R, Yajima T, Iwao Y, Yamazaki R et al. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 777–782.

    Article  CAS  Google Scholar 

  6. Verkruyse L, Storch G, Devine S, Dipersio J, Vij R . Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load>or=10 000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients. Bone Marrow Transplant 2006; 37: 51–56.

    Article  CAS  Google Scholar 

  7. Qamruddin A, Oppenheim B, Guiver M, Mutton K, Chopra R . Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection. Bone Marrow Transplant 2001; 27: 301–306.

    Article  CAS  Google Scholar 

  8. Cortez K, Fischer SH, Fahle GA, Calhoun LB, Childs RW, Barrett AJ et al. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis 2003; 188: 967–972.

    Article  CAS  Google Scholar 

  9. Sanchez J, Storch G . Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol 2002; 40: 2381–2386.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Warren Grant Magnuson Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    S M Harrington, L Li, S H Fischer & P R Murray

  2. Department of Pediatrics, Washington University School of Medicine, St Louis, MO, USA

    R S Buller & G A Storch

  3. Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    J C Gea-Banacloche

Authors
  1. S M Harrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R S Buller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G A Storch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S H Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P R Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J C Gea-Banacloche
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S M Harrington.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harrington, S., Buller, R., Storch, G. et al. The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. Bone Marrow Transplant 39, 237–238 (2007). https://doi.org/10.1038/sj.bmt.1705558

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705558

  • Springer Nature Limited

Search

Navigation